PLoS ONE · 2020 · 33 citations · 28 references
MedicineCancer BiologyOncologyMetastasisMolecular OncologyTumor ProgressionMalignant NeoplasmsNoncoding Rna In CancerSignal Transduction In CancerMelatonin TreatmentMetastatic MechanismsMicrorna Regulation In CancerMyc OverexpressionPineal Gland FunctionPineal Gland PhysiologyTriple-negative Breast Cancer TherapyTumor Cell Proliferation
Melatonin, a hormone secreted by pineal gland, exerts antimetastatic effects by reducing tumor cell proliferation, migration and invasion. MicroRNAs (miRNAs) are small, non-coding RNAs that play a crucial role in regulation of gene expression and biological processes of the cells. Herein, we search for a link between the tumor/metastatic-suppressive actions of melatonin and miRNA expression in triple-negative breast cancer cells. We demonstrated that melatonin exerts its anti-tumor actions by reducing proliferation, migration and c-Myc expression of triple negative breast cancer cells. By using Taqman-based assays, we analyzed the expression levels of a set of miRNAs following melatonin treatment of triple negative breast cancer cells and we identified 17 differentially expressed miRNAs, 6 down-regulated and 11 up-regulated. We focused on the anti-metastatic miR-148b and the oncogenic miR-210 both up-regulated by melatonin treatment and studied the effect of their modulation on melatonin-mediated impairment of tumor progression. Surprisingly, when miR-148b or miR-210 were depleted in triple-negative breast cancer cells, using a specific miR-148b sponge or anti-miR-210, melatonin effects on migration inhibition and c-myc downregulation were still visible suggesting that the increase of miR-148b and miR-210 expression observed following melatonin treatment was not required for the efficacy of melatonin action. Nevertheless, ours results suggest that melatonin exhibit a compound for metastatic trait inhibition, especially in MDA-MB-231 breast cancer cells even if a direct link between modulation of expression of certain proteins or miRNAs and melatonin effects has still to be established.
28
MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT
Zhan Zhang, Hong Sun, Hongyue Dai et al. · Cell Cycle · 2009 · 282 citations · Full text
microRNA‐214 contributes to melanoma tumour progression through suppression of TFAP2C
Elisa Penna, Francesca Orso, Daniela Cimino et al. · The EMBO Journal · 2011 · 262 citations · Full text